Back to Search
Start Over
Supplementary Figure 3 from Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file, 78K, Treatment of mice with human lung cancer HCC827/ER xenografts using a combination of erlotinib and niclosamide results in a long term tumor-free survival.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1edf04b65457e9318692a21d1116d6c5